Catalog No.
YHD93801
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Arg210-Glu272
Predicted molecular weight
21.65 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P31269
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
HOXA9, HOX1G, Homeobox protein Hox-1G, Homeobox protein Hox-A9
HOX-PBX Up-regulation Predicts Favorable Prognosis in NPM1-mutated Normal Cytogenetic AML via WNT Signaling., PMID:40295061
O-GlcNAc-modified HOXA9 suppresses ferroptosis via promoting UBR5-mediated SIRT6 degradation in nasopharyngeal carcinoma., PMID:40081214
Variability in expression of homeobox genes (HOXA9) and (HOXA7) in acute myeloid leukemia patients., PMID:40058172
HOXA9 and HOXA13 along with their shared gene targets act as common immune biomarkers in recurrent implantation failure and pre-eclampsia., PMID:40020429
HOXA9 methylation is not associated with survival in Brazilian patients with lung adenocarcinoma., PMID:39962529
Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia., PMID:39920624
Oncogenic role of RARG rearrangements in acute myeloid leukemia resembling acute promyelocytic leukemia., PMID:39805831
The role of the circ_DOCK1-miR-1297-HOXA9 regulatory network in the development of oral squamous cell carcinoma., PMID:39721095
[A two-site combined prediction model based on HOXA9 DNA methylation for early screening of risks of meningioma progression]., PMID:39623266
NAT10-mediated mRNA N4-acetylcytidine reprograms serine metabolism to drive leukaemogenesis and stemness in acute myeloid leukaemia., PMID:39506072
HOXA9 and CD163 potentiate pancreatic ductal adenocarcinoma progression., PMID:39462379
A Genome Wide CRISPR Screen Reveals That HOXA9 Promotes Enzalutamide Resistance in Prostate Cancer., PMID:39300912
HOXA9 promotes proliferation, metastasis and prevents apoptosis in hepatocellular carcinoma., PMID:39292289
[Changes in Serum HOXA9 , PCⅢ, SE-CAD Levels in AML Patients after Chemotherapy with DCAG Regimen and Their Relationship with Prognosis]., PMID:39192387
HOXA9 Regulome and Pharmacological Interventions in Leukemia., PMID:39017854
PHF6 suppresses self-renewal of leukemic stem cells in AML., PMID:39004675
Pan-cancer exploration of oncogenic and clinical impacts revealed that HOXA9 is a diagnostic indicator of tumorigenesis., PMID:38904676
The intrinsically disordered transactivation region of HOXA9 regulates its function by auto-inhibition of its DNA-binding activity., PMID:38825283
HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis., PMID:38753266
Desflurane alleviates LPS-induced acute lung injury by modulating let-7b-5p/HOXA9 axis., PMID:38676899
HOXA9 and β-catenin safeguard HSC integrity., PMID:38635250
RNA-binding protein RBM5 plays an essential role in acute myeloid leukemia by activating the oncogenic protein HOXA9., PMID:38216972
[Effects of circ-SFMBT2 on Proliferation, Migration and Invasion of Acute Myeloid Leukemia Cells by Regulating miR-491-5p/HOXA9 Axis]., PMID:38071034
HOXA9 transcription factor is a double-edged sword: from development to cancer progression., PMID:38062297
Homeobox A9 is a novel mediator of vascular smooth muscle cell phenotypic switching and proliferation by regulating methyl-CpG binding protein 2., PMID:37127144
HOXA9 gene promotor methylation and copy number variation of SOX2 and HV2 genes in cell free DNA: A potential diagnostic panel for non-small cell lung cancer., PMID:37038139
Genetic and phenotypic continuum of HOXA genes: A case with double HOXA9/HOXA13 mutations., PMID:36734258
A Live Cell Protein Complementation Assay for ORFeome-Wide Probing of Human HOX Interactomes., PMID:36611993
DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax., PMID:36593968
A pro B cell population forms the apex of the leukemic hierarchy in Hoxa9/Meis1-dependent AML., PMID:36517672
HOXA9 has the hallmarks of a biological switch with implications in blood cancers., PMID:36192425
circ_0052184 Promotes Colorectal Cancer Progression via Targeting miR-604/HOXA9 Axis., PMID:36065412
False-positive IRESes from Hoxa9 and other genes resulting from errors in mammalian 5' UTR annotations., PMID:36037358
Downregulation of hsa-miR-548d-3p and overexpression of HOXA9 in diffuse large B-cell lymphoma patients and the risk of R-CHOP chemotherapy resistance and disease progression., PMID:35830966
HOXA9 Overexpression Contributes to Stem Cell Overpopulation That Drives Development and Growth of Colorectal Cancer., PMID:35743243
Comprehensive Landscape of HOXA2, HOXA9, and HOXA10 as Potential Biomarkers for Predicting Progression and Prognosis in Prostate Cancer., PMID:35372588
Long non-coding RNA PCED1B-AS1 promotes the proliferation of colorectal adenocarcinoma through regulating the miR-633/HOXA9 axis., PMID:35176937
miR-652 Inhibits the Proliferation, Migration, and Invasion of Osteosarcoma Cells by Targeting HOXA9 and Regulating the PI3K/Akt Signaling Pathway., PMID:35111226
Circular RNA circFADS2 inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-766-3p/HOXA9 axis., PMID:34913472
The Retinoblastoma Tumor Suppressor Is Required for the NUP98-HOXA9-Induced Aberrant Nuclear Envelope Phenotype., PMID:34831074
Molecular regulators of HOXA9 in acute myeloid leukemia., PMID:34743404
One-pot three-component synthesis of novel pyrazolo[3,4-b]pyridines as potent antileukemic agents., PMID:34731763
miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9., PMID:34719830
DOT1L O-GlcNAcylation promotes its protein stability and MLL-fusion leukemia cell proliferation., PMID:34551297
HOXA9-methylated DNA as a diagnostic biomarker of ovarian malignancy., PMID:34514844
A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML., PMID:34502319
HOXA9-induced chemerin signals through CMKLR1/AMPK/TXNIP/NLRP3 pathway to induce pyroptosis of trophoblasts and aggravate preeclampsia., PMID:34461109
MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway., PMID:34416888
A genetic screen in Drosophila uncovers the multifaceted properties of the NUP98-HOXA9 oncogene., PMID:34383740
HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways., PMID:34310280
For research use only. Not for human or drug use.
